NKGen Biotech, Inc. (NKGN)
NASDAQ: NKGN · Real-Time Price · USD
0.640
+0.075 (13.25%)
Dec 20, 2024, 4:00 PM EST - Market closed
NKGen Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -88.25 | -82.95 | -26.75 | -23.27 |
| Depreciation & Amortization | 1.25 | 1.2 | 1.21 | 1.24 |
| Stock-Based Compensation | 4.11 | 4.14 | 0.07 | 0.09 |
| Other Operating Activities | 56.55 | 53.44 | 2.89 | 1.45 |
| Change in Accounts Receivable | - | 0.03 | -0.03 | 0.11 |
| Change in Accounts Payable | 5.26 | 3.99 | 0.44 | 0.96 |
| Change in Other Net Operating Assets | -0.46 | -1.8 | -0.38 | -0.14 |
| Operating Cash Flow | -21.54 | -21.95 | -22.56 | -19.55 |
| Capital Expenditures | - | - | -0.1 | -0.4 |
| Sale (Purchase) of Intangibles | -0.03 | -0.05 | -0.06 | -0.06 |
| Investing Cash Flow | 0 | -0.05 | -0.16 | -0.46 |
| Short-Term Debt Issued | - | 10.29 | 23 | 20.5 |
| Long-Term Debt Issued | - | 16.22 | - | - |
| Total Debt Issued | 22.62 | 26.51 | 23 | 20.5 |
| Short-Term Debt Repaid | - | -0.3 | -0.68 | -0.4 |
| Total Debt Repaid | -0.3 | -0.3 | -0.68 | -0.4 |
| Net Debt Issued (Repaid) | 22.32 | 26.21 | 22.33 | 20.1 |
| Issuance of Common Stock | 1.67 | 1.68 | 0.16 | 0.06 |
| Other Financing Activities | -3.59 | -5.73 | - | - |
| Financing Cash Flow | 20.39 | 22.16 | 22.49 | 20.16 |
| Net Cash Flow | -1.14 | 0.16 | -0.23 | 0.15 |
| Free Cash Flow | -21.54 | -21.95 | -22.66 | -19.95 |
| Free Cash Flow Margin | - | - | -29425.97% | -4683.33% |
| Free Cash Flow Per Share | -1.06 | -1.42 | -3.56 | -1.40 |
| Levered Free Cash Flow | 12.75 | 11.32 | -16.94 | - |
| Unlevered Free Cash Flow | 14.22 | 11.78 | -15.5 | - |
| Change in Net Working Capital | -28.53 | -25.08 | 1.4 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.